Sherbrooke Park Advisers »

Maxcyte shares owned by Sherbrooke Park Advisers

Quarter-by-quarter ownership of Maxcyte (MXCT) shares owned by Sherbrooke Park Advisers from 13F filings

Historical chart of Sherbrooke Park Advisers investment in Maxcyte

Tip: Access up to 7 years of quarterly data

All positions including Maxcyte held by Sherbrooke Park Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maxcyte by Sherbrooke Park Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $152k 32k 4.70

More positions owned by Sherbrooke Park Advisers

Procter & Gamble Company (PG)
Cardinal Health (CAH)
Hologic (HOLX)
Costco Wholesale Corporation (COST)
Motorola Solutions Com New (MSI)
Owens Corning (OC)
Teradata Corporation (TDC)
Marathon Petroleum Corp (MPC)
Johnson & Johnson (JNJ)
Coca-Cola Company (KO)
Starbucks Corporation (SBUX)
Verisk Analytics (VRSK)
Jabil Circuit (JBL)
United Therapeutics Corporation (UTHR)
Molson Coors Beverage CL B (TAP)

View all positions for Sherbrooke Park Advisers

Top funds holding Maxcyte

Cadian Capital Management
Vanguard Group
Vitruvian Partners
Millennium Management
Portolan Capital Management
Massachusetts Financial Services
Blue Water Life Science Advisors
River & Mercantile Asset Management
Arrowpoint Asset Management
Dimensional Fund Advisors
Willis Investment Counsel
Fred Alger Management
Roubaix Capital
Lazard Asset Management
Bank of New York Mellon

View all funds holding Maxcyte